Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
J Hepatol. 2018 Sep;69(3):594-602. doi: 10.1016/j.jhep.2018.04.005. Epub 2018 Apr 27.
BACKGROUND & AIMS: To affect immune response and inflammation, the hepatitis C virus (HCV) substantially influences intercellular communication pathways that are decisive for immune cell recruitment. The present study investigates mechanisms by which HCV modulates chemokine-mediated intercellular communication from infected cells.
Chemokine expression was studied in HCV-infected cell lines or cell lines harbouring a subgenomic replicon, as well as in serum samples from patients. Expression or activity of mediators and signalling intermediates was manipulated using knockdown approaches or specific inhibitors.
HCV enhances expression of CXCR2 ligands in its host cell via the induction of epidermal growth factor (EGF) production. Knockdown of EGF or of the p65 subunit of the NF-κB complex results in a substantial downregulation of HCV-induced CXCR2 ligand expression, supporting the involvement of an EGF-dependent mechanism as well as activation of NF-κB. Furthermore, HCV upregulates expression of CXCR2 ligands in response to EGF stimulation via downregulation of the T-cell protein tyrosine phosphatase (TC-PTP [PTPN2]), activation of NF-κB, and enhancement of EGF-inducible signal transduction via MEK1 (MAP2K1). This results in the production of a cytokine/chemokine pattern by the HCV-infected cell that can recruit neutrophils but not monocytes.
These data reveal a novel EGF-dependent mechanism by which HCV influences chemokine-mediated intercellular communication. We propose that this mechanism contributes to modulation of the HCV-induced inflammation and the antiviral immune response.
In most cases hepatitis C virus (HCV) results in chronic infection and persistent viral replication, taking decades until development of overt disease. To achieve such a course, the respective virus must have developed mechanisms to circumvent antiviral response, to modulate the inflammatory response and to utilise the infrastructure of its host with moderate effect on its viability. The present study provides novel data indicating that HCV induces epidermal growth factor production in its host cell, enhancing epidermal growth factor-inducible expression of chemokines that bind to the CXCR2 receptor and recruit neutrophile granulocytes. Importantly, chemokines are critical mediators determining the pattern of immune cells recruited to the site of injury and thereby the local inflammatory and immunological milieu. These data strongly suggest that HCV triggers mechanisms that enable the virus to influence the inflammatory and immunological processes of its host.
丙型肝炎病毒(HCV)对细胞间通讯途径产生重大影响,从而影响免疫反应和炎症,这些途径对免疫细胞的募集至关重要。本研究旨在探讨 HCV 调节受感染细胞中趋化因子介导的细胞间通讯的机制。
在 HCV 感染的细胞系或携带亚基因组复制子的细胞系中以及来自患者的血清样本中研究趋化因子的表达。使用敲低方法或特异性抑制剂来操纵介质和信号转导中间物的表达或活性。
HCV 通过诱导表皮生长因子(EGF)的产生来增强其宿主细胞中 CXCR2 配体的表达。EGF 或 NF-κB 复合物 p65 亚基的敲低导致 HCV 诱导的 CXCR2 配体表达的显著下调,支持涉及 EGF 依赖性机制以及 NF-κB 的激活。此外,HCV 通过下调 T 细胞蛋白酪氨酸磷酸酶(TC-PTP[PTPN2])、激活 NF-κB 以及增强 MEK1(MAP2K1)诱导的 EGF 信号转导,对 EGF 刺激作出反应而上调 CXCR2 配体的表达。这导致受 HCV 感染的细胞产生一种细胞因子/趋化因子模式,可募集中性粒细胞但不能募集单核细胞。
这些数据揭示了 HCV 影响趋化因子介导的细胞间通讯的新型 EGF 依赖性机制。我们提出,这种机制有助于调节 HCV 诱导的炎症和抗病毒免疫反应。
在大多数情况下,丙型肝炎病毒(HCV)导致慢性感染和持续的病毒复制,需要数十年时间才会出现明显的疾病。为了达到这种情况,相应的病毒必须开发出逃避抗病毒反应、调节炎症反应以及利用其宿主基础设施的机制,同时对其生存能力的影响适中。本研究提供了新的数据,表明 HCV 在其宿主细胞中诱导表皮生长因子的产生,增强表皮生长因子诱导的趋化因子的表达,这些趋化因子与 CXCR2 受体结合并募集中性粒细胞。重要的是,趋化因子是决定募集到损伤部位的免疫细胞模式的关键介质,从而决定局部炎症和免疫环境。这些数据强烈表明,HCV 触发了使病毒能够影响其宿主的炎症和免疫过程的机制。